Trial AMPlify Launches a Clinical Trial Website for Alumis
Trial AMPlify is proud to launch a new Plaque Psoriasis clinical trial website to investigate the possibility of clearer skin.

Alumis is currently recruiting patients to participate in the ONWARD clinical study. The trial is seeking to enroll patients with plaque psoriasis to help evaluate efficacy and safety of an investigational oral TYK2 inhibitor, ESK-001. Psoriasis can be painful to live with and affect your quality of life. Atossa hopes to bring relief through this study.
View the clinical study site here - https://www.onwardclinicalstudy.com/